Ariel Halper-Stromberg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ariel Halper-Stromberg

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The Journal of Experimental Medicine|November 12, 2014

Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variantsFlorian Klein, Lilian Nogueira, Yoshiaki Nishimura, et al.

Nature|October 30, 2012

HIV therapy by a combination of broadly neutralizing antibodies in humanized miceFlorian Klein, Ariel Halper-Stromberg, Joshua A Horwitz, et al.

Science Translational Medicine|January 20, 2017

Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The Journal of Experimental Medicine|November 12, 2014

Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variantsFlorian Klein, Lilian Nogueira, Yoshiaki Nishimura, et al.

Nature|October 30, 2012

HIV therapy by a combination of broadly neutralizing antibodies in humanized miceFlorian Klein, Ariel Halper-Stromberg, Joshua A Horwitz, et al.

Science Translational Medicine|January 20, 2017

Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.

Pageof 2